Evidence map›Paper›PMID 29627295›Full record

ArticleJournal of molecular and cellular cardiology2018

Deficiency of aldose reductase exacerbates early pressure overload-induced cardiac dysfunction and autophagy in mice.

Shahid P Baba, Deqing Zhang, Mahavir Singh, Sujith Dassanayaka, Zhengzhi Xie, Ganapathy Jagatheesan, Jingjing Zhao, Virginia K Schmidtke, Kenneth R Brittian, Michael L Merchant and 3 more

Open access · greenAbstract read
In one paragraph

Article in Journal of molecular and cellular cardiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 38 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Advances in Metabolic Remodeling and Intervention Strategies in Heart Failure.Journal of cardiovascular translational research · 2024
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Chronic Benzene Exposure Aggravates Pressure Overload-Induced Cardiac Dysfunction.Toxicological sciences : an official journal of the Society of Toxicology · 2021
    Article
  16. Cardiac PANK1 deletion exacerbates ventricular dysfunction during pressure overload.American journal of physiology. Heart and circulatory physiology · 2021
    Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Shahid P BabaDiabetes and Obesity Center, University of Louisville, Louisville, KY, United States. Electronic address: spbaba01@louisville.edu.
Deqing ZhangDiabetes and Obesity Center, University of Louisville, Louisville, KY, United States.
Mahavir SinghDepartment of Physiology, University of Louisville, Louisville, KY, United States.
Sujith DassanayakaDiabetes and Obesity Center, University of Louisville, Louisville, KY, United States.
Zhengzhi XieDiabetes and Obesity Center, University of Louisville, Louisville, KY, United States.
Ganapathy JagatheesanDiabetes and Obesity Center, University of Louisville, Louisville, KY, United States.
Jingjing ZhaoDiabetes and Obesity Center, University of Louisville, Louisville, KY, United States.
Virginia K SchmidtkeDiabetes and Obesity Center, University of Louisville, Louisville, KY, United States.
Kenneth R BrittianDiabetes and Obesity Center, University of Louisville, Louisville, KY, United States.
Michael L MerchantDivisions of Nephrology and Hypertension and the Institute of Molecular Cardiology, University of Louisville, Louisville, KY, United States.
Daniel J ConklinDiabetes and Obesity Center, University of Louisville, Louisville, KY, United States.
Steven P JonesDiabetes and Obesity Center, University of Louisville, Louisville, KY, United States.
Aruni BhatnagarDiabetes and Obesity Center, University of Louisville, Louisville, KY, United States.
University of Louisville · US

Funding

Tumor Necrosis Factor Modulation of CPCsP01HL078825 · NHLBI · UNIVERSITY OF LOUISVILLE · PI BOLLI, ROBERTO · 2005 to 2021
$37.6M
Role of oxidized linoleic acid metabolites in the pathogenesis of alcoholic liver diseaseP20GM113226 · NIGMS · UNIVERSITY OF LOUISVILLE · PI GHARE, SMITA S · 2016 to 2025
$24.1M
Project 5 - Metabolomic Analysis of AtherothrombosisP20GM103492 · NIGMS · UNIVERSITY OF LOUISVILLE · PI DEFILIPPIS, ANDREW · 2012 to 2017
$13.8M
TBDP30GM127607 · NIGMS · UNIVERSITY OF LOUISVILLE · PI HILL, BRADFORD GUY · 2018 to 2022
$6.3M
TOXICITY OF 4-HYDROXYALKENALS IN HEARTR01HL055477 · NHLBI · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI BHATNAGAR, ARUNI · 1997 to 2015
$4.4M
CARDIAC METABOLISM OF ENALSR01HL059378 · NHLBI · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI BHATNAGAR, ARUNI · 1998 to 2011
$3.3M
Cardiac pathophysiology of histidyl dipeptidesR01HL122581 · NHLBI · UNIVERSITY OF LOUISVILLE · PI BABA, SHAHID P · 2014 to 2018
$2.8M
Regulation of Metabolic Genes in the HeartR01HL131647 · NHLBI · UNIVERSITY OF LOUISVILLE · PI JONES, STEVEN P · 2016 to 2019
$2.2M
Metabolic Mechanisms of Cardiac Injury and ProtectionR01HL083320 · NHLBI · UNIVERSITY OF LOUISVILLE · PI JONES, STEVEN P · 2006 to 2010
$1.8M
O-GlcNAc Signaling in Heart FailureR01HL094419 · NHLBI · UNIVERSITY OF LOUISVILLE · PI JONES, STEVEN P · 2009 to 2012
$1.5M
Vascular Toxicity of AldehydesR01ES012062 · NIEHS · UNIVERSITY OF LOUISVILLE · PI BHATNAGAR, ARUNI BHATNAGAR · 2003 to 2006
$1.4M
NHLBI NIH HHS P01 HL078825NHLBI NIH HHS R01 HL055477NHLBI NIH HHS R01 HL059378NHLBI NIH HHS R01 HL083320NHLBI NIH HHS R01 HL094419NHLBI NIH HHS R01 HL122581NHLBI NIH HHS R01 HL131647NIEHS NIH HHS R01 ES012062NIGMS NIH HHS P20 GM103492NIGMS NIH HHS P20 GM113226NIGMS NIH HHS P30 GM127607
6 · The paper itself

Abstract

Pathological cardiac hypertrophy is associated with the accumulation of lipid peroxidation-derived aldehydes such as 4-hydroxy-trans-2-nonenal (HNE) and acrolein in the heart. These aldehydes are metabolized via several pathways, of which aldose reductase (AR) represents a broad-specificity route for their elimination. We tested the hypothesis that by preventing aldehyde removal, AR deficiency accentuates the pathological effects of transverse aortic constriction (TAC). We found that the levels of AR in the heart were increased in mice subjected to TAC for 2 weeks. In comparison with wild-type (WT), AR-null mice showed lower ejection fraction, which was exacerbated 2 weeks after TAC. Levels of atrial natriuretic peptide and myosin heavy chain were higher in AR-null than in WT TAC hearts. Deficiency of AR decreased urinary levels of the acrolein metabolite, 3-hydroxypropylmercapturic acid. Deletion of AR did not affect the levels of the other aldehyde-metabolizing enzyme - aldehyde dehydrogenase 2 in the heart, or its urinary product - (N-Acetyl-S-(2-carboxyethyl)-l-cystiene). AR-null hearts subjected to TAC showed increased accumulation of HNE- and acrolein-modified proteins, as well as increased AMPK phosphorylation and autophagy. Superfusion with HNE led to a greater increase in p62, LC3II formation, and GFP-LC3-II punctae formation in AR-null than WT cardiac myocytes. Pharmacological inactivation of JNK decreased HNE-induced autophagy in AR-null cardiac myocytes. Collectively, these results suggest that during hypertrophy the accumulation of lipid peroxidation derived aldehydes promotes pathological remodeling via excessive autophagy, and that metabolic detoxification of these aldehydes by AR may be essential for maintaining cardiac function during early stages of pressure overload.

Indexed as

AutophagyPressureAldehyde ReductaseAldehydesAnimalsAortaCardiomegalyConstriction, PathologicGene DeletionHeartJNK Mitogen-Activated Protein KinasesMaleMice, Inbred C57BLMyocardial ContractionMyocardiumSequestosome-1 Protein4-hydroxy-2-nonenalAldehyde ReductaseAldehydesJNK Mitogen-Activated Protein KinasesSequestosome-1 ProteinSqstm1 protein, mouseAcroleinAutophagyCarnosineHydroxynonenalHypertrophy

Identifiers

PMID29627295
PMCPMC6205513
OpenAlexW2795410215

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.